Renaissance Technologies - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 30 filers reported holding KURA ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,054
-47.0%
115,600
-38.5%
0.00%
-33.3%
Q2 2023$1,990
+880.3%
188,100
+1033.1%
0.00%
Q1 2023$203
-100.0%
16,600
-86.7%
0.00%
-100.0%
Q3 2022$1,701,000
-36.0%
124,500
-14.1%
0.00%
-33.3%
Q2 2022$2,658,000
-40.6%
145,000
-47.9%
0.00%
-40.0%
Q1 2022$4,477,000
+372.3%
278,400
+311.2%
0.01%
+400.0%
Q4 2021$948,000
-70.9%
67,700
-61.1%
0.00%
-75.0%
Q3 2021$3,261,000
-48.2%
174,100
-42.4%
0.00%
-50.0%
Q2 2021$6,301,000
+643.0%
302,200
+254.4%
0.01%
+700.0%
Q1 2020$848,000
-37.9%
85,271
-4.5%
0.00%
-50.0%
Q4 2017$1,366,000
-65.7%
89,294
-66.5%
0.00%
-60.0%
Q3 2017$3,983,000
+375.9%
266,400
+196.0%
0.01%
+400.0%
Q2 2017$837,000
+20.1%
90,000
+13.6%
0.00%0.0%
Q1 2017$697,000
+285.1%
79,200
+158.8%
0.00%
Q4 2016$181,000
+18.3%
30,600
+25.4%
0.00%
Q3 2016$153,000
+325.0%
24,400
+83.5%
0.00%
Q2 2016$36,00013,3000.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders